Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization

Abstract

Patients with heart disease are frequently treated with supplemental oxygen. Although oxygen can exhibit vasoactive properties in many vascular beds, its effects on the coronary circulation have not been fully characterized. To examine whether supplemental oxygen administration affects coronary blood flow (CBF) in a clinical setting, we measured in 18 patients with stable coronary heart disease the effects of breathing 100% oxygen by face mask for 15 min on CBF (via coronary Doppler flow wire), conduit coronary diameter, CBF response to intracoronary infusion of the endothelium-dependent dilator ACh and to the endothelium-independent dilator adenosine, as well as arterial and coronary venous concentrations of the nitric oxide (NO) metabolites nitrotyrosine, NO(2)(-), and NO(3)(-). Relative to breathing room air, breathing of 100% oxygen increased coronary resistance by approximately 40%, decreased CBF by approximately 30%, increased the appearance of nitrotyrosine in coronary venous plasma, and significantly blunted the CBF response to ACh. Oxygen breathing elicited these changes without affecting the diameter of large-conduit coronary arteries, coronary venous concentrations of NO(2)(-) and NO(3)(-), or the coronary vasodilator response to adenosine. Administering supplemental oxygen to patients undergoing cardiac catheterization substantially increases coronary vascular resistance by a mechanism that may involve oxidative quenching of NO within the coronary microcirculation.

To Give or Not To Give - Is that the Question?: The Changing Face of Emergency Oxygen Therapy

“…In 1969 Bourassa et al [33] reported from experimental studies that high flow oxygen can reduce coronary blood flow sufficiently to worsen outcomes. More recently McNulty et al [34] provided evidence that high flow oxygen reduces coronary artery blood flow and confirmed the previously evidence base. Yet the practice of using high flow oxygen persisted and was endorsed for years, and despite subsequent changes in guidelines [1,12], there is evidence that the ritual still persists [35].…”

WHO Needs High FIO2?

“…In the lung it has been observed decreased mucociliar transport, inflammatory reaction, focal pulmonary edema, interstitial fibrosis and reabsorption atelectasis. In the cardiocirculatory system, higher oxygen tension decreases cardiac output and stroke volume with increased peripheral vascular resistances and coronary artery vasoconstriction (66)(67)(68)(69). The peripheral vasoconstriction, in particular, may explain the possible gap between high PaO 2 and low tissue oxygen tension.…”

Should Oxygen Therapy Be Tightly Regulated to Minimize Hyperoxia in Critically Ill Patients?

“…[99][100][101] Kilgannon et al 63 have demonstrated that hyperoxia played a greater role in mortality than did hypoxia following cardiac arrest. A number of other investigations and meta-analyses 102-107 on this subject have been published following the work of Kilgannon.…”